Inventor · disambiguated record
Joyce I. Meesters
Also filed as: MEESTERS JOYCE · MEESTERS JOYCE I
15 granted patents·13 pending applications·301 citations·filing 2011–2024
94Inventor score
Top patents by PatentIndex Score
28 records- 0198US11485796B2Inert formatGENMAB AS·Filed 2020·Granted Nov 1, 2022·6 cites·20 claims
- 0297US11866514B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2020·Granted Jan 9, 2024·5 cites·37 claims
- 0397US10597464B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2017·Granted Mar 24, 2020·35 cites·12 claims
- 0497US9150663B2Heterodimeric antibody Fc-containing proteins and methods for production thereofLABRIJN ARAN FRANK·Filed 2011·Granted Oct 6, 2015·119 cites·37 claims
- 0596US10590206B2Inert formatGENMAB AS·Filed 2014·Granted Mar 17, 2020·29 cites·20 claims
- 0695US10344050B2Production of heterodimeric proteinsGENMAB AS·Filed 2012·Granted Jul 9, 2019·40 cites·52 claims
- 0794US10407501B2Humanized or chimeric CD3 antibodiesGENMAB AS·Filed 2015·Granted Sep 10, 2019·15 cites·19 claims
- 0893US11492371B2Production of heterodimeric proteinsGENMAB AS·Filed 2019·Granted Nov 8, 2022·9 cites·21 claims
- 0992US11613575B2Humanized or chimeric CD3 antibodiesGENMAB AS·Filed 2019·Granted Mar 28, 2023·4 cites·18 claims
- 1091US10465006B2Humanized or chimeric CD3 antibodiesGENMAB·Filed 2014·Granted Nov 5, 2019·18 cites·19 claims
- 1190US9862769B2Monoclonal antibodies against HER2DE GOEIJ BART·Filed 2011·Granted Jan 9, 2018·16 cites·42 claims
- 1286US2024209117A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2023·Application pending·0 cites
- 1385US11046771B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Jun 29, 2021·2 cites·23 claims
- 1483US2023374131A1Humanized or chimeric cd3 antibodiesGENMAB AS·Filed 2023·Application pending·0 cites
- 1581US11578141B2Bispecific antibodies against HER2 and CD3GENMAB AS·Filed 2019·Granted Feb 14, 2023·1 cites·11 claims
- 1680US11091553B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Aug 17, 2021·1 cites·20 claims
- 1780US2025066506A1Bispecific antibodies against her2GENMAB AS·Filed 2024·Application pending·0 cites
- 1879US2023322947A1Inert formatGENMAB AS·Filed 2022·Application pending·0 cites
- 1973US2022169738A1Monoclonal antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 2073US2023227495A1Production of heterodimeric proteinsGENMAB AS·Filed 2022·Application pending·0 cites
- 2172US2020123255A1Humanized or chimeric cd3 antibodiesGENMAB AS·Filed 2019·Application pending·0 cites
- 2268US10865253B2Rodent bispecific heterodimeric proteinsGENMAB AS·Filed 2015·Granted Dec 15, 2020·1 cites·14 claims
- 2367US2021324105A1Bispecific antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 2455US2016046727A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2015·Application pending·0 cites
- 2553US2017369590A1Bispecific antibodies against her2GENMAB AS·Filed 2017·Application pending·0 cites
- 2653US2017369594A1Bispecific antibodies against her2 and cd3GENMAB AS·Filed 2017·Application pending·0 cites
- 2750US2014170149A1Bispecific antibodies against her2 and cd3NEIJSSEN JOOST J·Filed 2012·Application pending·0 cites
- 2841US2014170148A1Bispecific antibodies against her2DE GOEIJ BART·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →